Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Market movers: UnitedHealth Group, GE Aerospace, RTX Corporation, Lucid Group…

RTX Corporation (NYSE:RTX) reported stronger-than-expected first-quarter 2026 results, delivering an earnings and revenue beat driven by broad-based strength across its defense and commercial aerospace businesses.

The company reported adjusted earnings per share (EPS) of $1.78, ahead of analyst expectations of roughly $1.52.

Read more

Shares of Lucid Group Inc (NASDAQ:LCID) rose 10.3% on Tuesday morning, with the electric vehicle maker drawing attention after a series of capital deals and renewed takeover speculation following recent fundraising activity.

The move came after Lucid disclosed that Uber Technologies will invest an additional $200 million in the company, bringing Uber’s total investment to $500 million.

Read more

Halliburton Company (NYSE:HAL, XETRA:HAL) reported first-quarter profit and revenue above Wall Street expectations on Tuesday, as strength in both North American and international operations lifted results.

The oilfield services company posted revenue of $5.4 billion for the quarter ended March 31, compared with analysts’ estimate of $5.3 billion, according to data compiled by LSEG.

Read more

DR Horton Inc (NYSE:DHI) reported quarterly earnings that beat Wall Street expectations on both revenue and profit on Tuesday, even as net income declined year over year and homebuilding revenue softened.

The US homebuilder posted revenue of $7.56 billion for its fiscal second quarter ended March 31, compared with analyst expectations of $7.55 billion.

Read more

VivoPower PLC (NASDAQ:VIVO, FRA:51J) said on Tuesday it has become EBITDA profitable following the completion of its $41 million acquisition of data center assets in Norway, marking a shift to positive earnings on a pro forma basis.

The Nasdaq-listed company reported that the acquired operations are expected to contribute about $31 million in annual revenue and roughly $10 million in annual EBITDA, compared with pre-acquisition annual revenue of about $0.1 million and negative EBITDA of $8.2 million.

Read more

UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares rose more than 10% on Tuesday after the company reported first quarter results that exceeded Wall Street expectations and raised its full-year profit forecast, citing improved management of medical costs and ongoing operational changes.

The private health insurer said it now expects 2026 adjusted earnings of more than $18.25 per share, up from a prior outlook of more than $17.75 per share.

Read more

3M Co (NYSE:MMM) reported first-quarter earnings that topped Wall Street expectations, as margin improvement and cost controls helped offset slightly weaker-than-expected revenue.

The industrial conglomerate posted adjusted earnings per share of $2.14 for the quarter, above analysts’ estimate of $1.98 and up 14% from a year earlier.

Read more

GE Aerospace (NYSE:GE) reported better-than-expected first quarter financial results, driven by sharp growth in its commercial engines and services business and a significant increase in orders.

The company reported adjusted earnings per share (EPS) of $1.86, above the $1.60 analyst estimate, and adjusted revenue of $11.61 billion, compared with expectations of $10.71 billion.

Read more

Argentina Lithium & Energy Corp (TSX-V:LIT, OTCQX:LILIF) has announced a non-binding agreement with China-based Xi’an Lanshen New Material Technology to advance development of its Rincon West lithium brine project in Argentina’s Salta Province.

The agreement, described as a Heads of Terms and Framework Agreement, outlines a staged approach to technical development, financing, and potential commercial production at the project.

Read more

Shares in CRISM Therapeutics rose 19% to 14p on Tuesday after the AIM-quoted drug delivery company reported positive preclinical results for its Docetaxel-ChemoSeed implant technology in a prostate cancer model, showing a 58% reduction in tumour volume compared to standard treatment.

The study evaluated CRISM's ChemoSeed platform, which delivers chemotherapy drugs directly to tumour sites in a sustained, localised manner rather than through systemic administration, the conventional approach in which drugs are distributed throughout the body via the bloodstream.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK